Cargando…

The development of an end-to-end service solution to support lupus patients and improve their experience in clinical trials

OBJECTIVE: To develop an end-to-end clinical trial service to improve patient experience during trials, reduce the burden of participating in a trial, and increase trial retention. METHODS: A literature search and stakeholder interviews were used to identify current challenges and unmet needs of sys...

Descripción completa

Detalles Bibliográficos
Autores principales: Allen, Jodie, Child, Abbey, Mertens, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364094/
https://www.ncbi.nlm.nih.gov/pubmed/30428691
http://dx.doi.org/10.1177/1740774518811111
_version_ 1783393198467448832
author Allen, Jodie
Child, Abbey
Mertens, Sarah
author_facet Allen, Jodie
Child, Abbey
Mertens, Sarah
author_sort Allen, Jodie
collection PubMed
description OBJECTIVE: To develop an end-to-end clinical trial service to improve patient experience during trials, reduce the burden of participating in a trial, and increase trial retention. METHODS: A literature search and stakeholder interviews were used to identify current challenges and unmet needs of systemic lupus erythematosus patients and other systemic lupus erythematosus clinical trial stakeholders. The results from the literature search and interviews were used to create a five-phase map describing the current clinical trial experience of all stakeholders. A set of proposed solutions were developed to address the identified unmet needs and challenges. These solutions were presented to trial-experienced patients and study site personnel; any feedback obtained was used to further refine the solutions. RESULTS: Four site personnel and seven patients from three different systemic lupus erythematosus clinical trial sites were interviewed between September 2015 and December 2015. Key unmet needs and challenges were identified at each stage of the clinical trials. At the screening stage, some patients incorrectly thought they were successfully enrolled into the clinical trial. During enrollment, some patients found it difficult to keep fully informed about the trial and were unable to explain the trial process to loved ones. During the trial, patients struggled to prepare for study visits, felt overwhelmed by the trial process, and wanted someone to talk to for support. Clinical trial site personnel reported current key challenges as: delivering trial information clearly and consistently to patients, setting patient expectations, retaining enrolled patients, and providing non-clinical patient support. To address the needs of patients and site personnel, an end-to-end support service was designed, consisting of nine solutions: My Best Choice, My Eligibility, My Lupus Trial Kit, My Lupus Trial Coach, My Appointment Guide, My Clinic Compass, Our Gratitude, Building a Different Network, and My Next Chapter. CONCLUSION: The solutions proposed in this qualitative study may help improve the systemic lupus erythematosus clinical trial experience for patients, potentially helping to increase trial recruitment and retention. The solutions proposed here would also promote positive patient-trial personnel relationships, which may help site personnel identify patients at risk of early withdrawal, while ensuring that the time and resources of site personnel are used efficiently.
format Online
Article
Text
id pubmed-6364094
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-63640942019-02-25 The development of an end-to-end service solution to support lupus patients and improve their experience in clinical trials Allen, Jodie Child, Abbey Mertens, Sarah Clin Trials Recruitment and Retention OBJECTIVE: To develop an end-to-end clinical trial service to improve patient experience during trials, reduce the burden of participating in a trial, and increase trial retention. METHODS: A literature search and stakeholder interviews were used to identify current challenges and unmet needs of systemic lupus erythematosus patients and other systemic lupus erythematosus clinical trial stakeholders. The results from the literature search and interviews were used to create a five-phase map describing the current clinical trial experience of all stakeholders. A set of proposed solutions were developed to address the identified unmet needs and challenges. These solutions were presented to trial-experienced patients and study site personnel; any feedback obtained was used to further refine the solutions. RESULTS: Four site personnel and seven patients from three different systemic lupus erythematosus clinical trial sites were interviewed between September 2015 and December 2015. Key unmet needs and challenges were identified at each stage of the clinical trials. At the screening stage, some patients incorrectly thought they were successfully enrolled into the clinical trial. During enrollment, some patients found it difficult to keep fully informed about the trial and were unable to explain the trial process to loved ones. During the trial, patients struggled to prepare for study visits, felt overwhelmed by the trial process, and wanted someone to talk to for support. Clinical trial site personnel reported current key challenges as: delivering trial information clearly and consistently to patients, setting patient expectations, retaining enrolled patients, and providing non-clinical patient support. To address the needs of patients and site personnel, an end-to-end support service was designed, consisting of nine solutions: My Best Choice, My Eligibility, My Lupus Trial Kit, My Lupus Trial Coach, My Appointment Guide, My Clinic Compass, Our Gratitude, Building a Different Network, and My Next Chapter. CONCLUSION: The solutions proposed in this qualitative study may help improve the systemic lupus erythematosus clinical trial experience for patients, potentially helping to increase trial recruitment and retention. The solutions proposed here would also promote positive patient-trial personnel relationships, which may help site personnel identify patients at risk of early withdrawal, while ensuring that the time and resources of site personnel are used efficiently. SAGE Publications 2018-11-14 2019-02 /pmc/articles/PMC6364094/ /pubmed/30428691 http://dx.doi.org/10.1177/1740774518811111 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution 4.0 License (http://www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Recruitment and Retention
Allen, Jodie
Child, Abbey
Mertens, Sarah
The development of an end-to-end service solution to support lupus patients and improve their experience in clinical trials
title The development of an end-to-end service solution to support lupus patients and improve their experience in clinical trials
title_full The development of an end-to-end service solution to support lupus patients and improve their experience in clinical trials
title_fullStr The development of an end-to-end service solution to support lupus patients and improve their experience in clinical trials
title_full_unstemmed The development of an end-to-end service solution to support lupus patients and improve their experience in clinical trials
title_short The development of an end-to-end service solution to support lupus patients and improve their experience in clinical trials
title_sort development of an end-to-end service solution to support lupus patients and improve their experience in clinical trials
topic Recruitment and Retention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364094/
https://www.ncbi.nlm.nih.gov/pubmed/30428691
http://dx.doi.org/10.1177/1740774518811111
work_keys_str_mv AT allenjodie thedevelopmentofanendtoendservicesolutiontosupportlupuspatientsandimprovetheirexperienceinclinicaltrials
AT childabbey thedevelopmentofanendtoendservicesolutiontosupportlupuspatientsandimprovetheirexperienceinclinicaltrials
AT mertenssarah thedevelopmentofanendtoendservicesolutiontosupportlupuspatientsandimprovetheirexperienceinclinicaltrials
AT allenjodie developmentofanendtoendservicesolutiontosupportlupuspatientsandimprovetheirexperienceinclinicaltrials
AT childabbey developmentofanendtoendservicesolutiontosupportlupuspatientsandimprovetheirexperienceinclinicaltrials
AT mertenssarah developmentofanendtoendservicesolutiontosupportlupuspatientsandimprovetheirexperienceinclinicaltrials